Fusion expression of human beta-defensin 3 in E.coli and primary analysis of its antimicrobial activities
Tuo Xiao
Abstract
Tuo Xiao
Abstract
Objective: To express human beta-defensin 3 with antimicrobial activities in E.coli. Methods: DNA fragment encoding the mature peptide of human beta-defensin 3 were prepared by PCR with pGEM-T-hBD3 as template and then cloned into pGEX-4T-1. Clones carrying pGEX-4T-1-hBD3 was induced by IPTG. The bacteria were broken down by ultrasonic and the inclusion bodies obtained underwent denaturation, renaturation and purification to obtain GST-hBD3 fusion protein. The fusion protein was cleaved by thrombin to achieve recombinant form hBD3. The antimicrobial activity of the rhBD3 was assayed by minimal inhibitory concentration (MIC) method. Results: rhBD3 was expressed as GST-fusion protein in pGEX-4T-1 prokaryotic expression system. The fusion protein was present in the lysate as inclusion bodies. rhBD3 was released by thrombin digestion and demonstrated a MIC of 4 μg/ml against gram-positive S.aureus and 8 μg/ml against gram-negative E.coli. Conclusion: Recombinant hBD3 with antimicrobial activities was generated in pGEX-4T-1 fusion expression system.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To express human beta-defensin 3 with antimicrobial activities in E.coli. Methods: DNA fragment encoding the mature peptide of human beta-defensin 3 were prepared by PCR with pGEM-T-hBD3 as template and then cloned into pGEX-4T-1. Clones carrying pGEX-4T-1-hBD3 was induced by IPTG. The bacteria were broken down by ultrasonic and the inclusion bodies obtained underwent denaturation, renaturation and purification to obtain GST-hBD3 fusion protein. The fusion protein was cleaved by thrombin to achieve recombinant form hBD3. The antimicrobial activity of the rhBD3 was assayed by minimal inhibitory concentration (MIC) method. Results: rhBD3 was expressed as GST-fusion protein in pGEX-4T-1 prokaryotic expression system. The fusion protein was present in the lysate as inclusion bodies. rhBD3 was released by thrombin digestion and demonstrated a MIC of 4 μg/ml against gram-positive S.aureus and 8 μg/ml against gram-negative E.coli. Conclusion: Recombinant hBD3 with antimicrobial activities was generated in pGEX-4T-1 fusion expression system.
Key concepts: Beta defensin, Fusion protein, Defensin, Recombinant DNA, Antimicrobial, Inclusion bodies, Molecular biology, Escherichia coli